tickerreport.com
Neutralwww.tickerreport.com Β·
olema pharmaceuticals olma to release earnings on tuesday
TAX_FNCACT_INSIDERSWB_1973_FINANCIAL_RISK_REDUCTIONWB_435_AGRICULTURE_AND_FOOD_SECURITYWB_337_INSURANCE
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedEarnings release for a clinical-stage biotech company; no specific product or commercial catalyst mentioned. The event is company-specific with no direct commodity, supply chain, or regulatory impact. Weak commercial mechanism β only earnings announcement with no material operational changes.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources β not direct quotes from the publisher.
- Olema Pharmaceuticals (NASDAQ:OLMA) to release Q1 2026 earnings on May 12, 2026.
- Analysts predict a loss of $0.52 per share for Q1 2026.
- Insider Shawnte Mitchell sold 25,000 shares at $24.25 in March 2026.
- Stock opened at $14.90, market cap $1.30 billion, 52-week range $3.89-$36.26.
- Consensus rating 'Moderate Buy' with average target price $44.40.